These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 34367153)

  • 1. Plasma Sphingolipid Profile Associated With Subclinical Atherosclerosis and Clinical Disease Markers of Systemic Lupus Erythematosus: Potential Predictive Value.
    Hammad SM; Harden OC; Wilson DA; Twal WO; Nietert PJ; Oates JC
    Front Immunol; 2021; 12():694318. PubMed ID: 34367153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Race disparity in blood sphingolipidomics associated with lupus cardiovascular comorbidity.
    Hammad SM; Hardin JR; Wilson DA; Twal WO; Nietert PJ; Oates JC
    PLoS One; 2019; 14(11):e0224496. PubMed ID: 31747417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A panel of biomarkers is associated with increased risk of the presence and progression of atherosclerosis in women with systemic lupus erythematosus.
    McMahon M; Skaggs BJ; Grossman JM; Sahakian L; Fitzgerald J; Wong WK; Lourenco EV; Ragavendra N; Charles-Schoeman C; Gorn A; Karpouzas GA; Taylor MB; Watson KE; Weisman MH; Wallace DJ; Hahn BH
    Arthritis Rheumatol; 2014 Jan; 66(1):130-9. PubMed ID: 24449580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human low-affinity IgG receptor FcγRIIA polymorphism H131R associates with subclinical atherosclerosis and increased platelet activity in systemic lupus erythematosus.
    Clancy R; El Bannoudi H; Rasmussen SE; Bornkamp N; Allen N; Dann R; Reynolds H; Buyon JP; Berger JS
    J Thromb Haemost; 2019 Mar; 17(3):532-537. PubMed ID: 30638300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in subclinical cardiovascular disease between African American and Caucasian women with systemic lupus erythematosus.
    Rhew EY; Manzi SM; Dyer AR; Kao AH; Danchenko N; Barinas-Mitchell E; Sutton-Tyrrell K; McPherson DD; Pearce W; Edmundowicz D; Kondos GT; Ramsey-Goldman R
    Transl Res; 2009 Feb; 153(2):51-9. PubMed ID: 19138649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and subclinical cardiovascular disease in female SLE patients: Interplay between body mass index and bone mineral density.
    Rodríguez-Carrio J; Martínez-Zapico A; Cabezas-Rodríguez I; Benavente L; Pérez-Álvarez ÁI; López P; Cannata-Andía JB; Naves-Díaz M; Suárez A
    Nutr Metab Cardiovasc Dis; 2019 Feb; 29(2):135-143. PubMed ID: 30559042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-density lipoprotein net charge is a risk factor for atherosclerosis in lupus patients independent of lipid concentrations.
    Rodríguez M; Guardiola M; Oliva I; Carles Vallvé J; Ferré R; Masana L; Parra S; Ribalta J; Castro A
    Int J Rheum Dis; 2019 Mar; 22(3):480-487. PubMed ID: 30450745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease trends over time and CD4
    Baragetti A; Ramirez GA; Magnoni M; Garlaschelli K; Grigore L; Berteotti M; Scotti I; Bozzolo E; Berti A; Camici PG; Catapano AL; Manfredi AA; Ammirati E; Norata GD
    Nutr Metab Cardiovasc Dis; 2018 Jan; 28(1):53-63. PubMed ID: 29150407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingolipids and Diagnosis, Prognosis, and Organ Damage in Systemic Lupus Erythematosus.
    Harden OC; Hammad SM
    Front Immunol; 2020; 11():586737. PubMed ID: 33101319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocan Levels and Subclinical Atherosclerosis in Patients With Systemic Lupus Erythematosus.
    Icli A; Cure E; Cure MC; Uslu AU; Balta S; Mikhailidis DP; Ozturk C; Arslan S; Sakız D; Sahin M; Kucuk A
    Angiology; 2016 Sep; 67(8):749-55. PubMed ID: 26614790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum adiponectin levels are associated with presence of carotid plaque in women with systemic lupus erythematosus.
    Carbone F; Montecucco F; Poggi A; Nobili F; Cacciapaglia F; Afeltra A; Moccetti T; Colombo BM
    Nutr Metab Cardiovasc Dis; 2020 Jun; 30(7):1147-1151. PubMed ID: 32451275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Levels of Anti-PON1 and Anti-HDL Antibodies as Potential Biomarkers of Premature Atherosclerosis in Systemic Lupus Erythematosus.
    López P; Rodríguez-Carrio J; Martínez-Zapico A; Pérez-Álvarez ÁI; López-Mejías R; Benavente L; Mozo L; Caminal-Montero L; González-Gay MA; Suárez A
    Thromb Haemost; 2017 Nov; 117(11):2194-2206. PubMed ID: 29044294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of carotid atherosclerosis in systemic lupus erythematosus.
    Maksimowicz-McKinnon K; Magder LS; Petri M
    J Rheumatol; 2006 Dec; 33(12):2458-63. PubMed ID: 17014002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein-containing lipoprotein subclasses and subclinical atherosclerosis in systemic lupus erythematosus.
    Kiani AN; Fang H; Akhter E; Quiroga C; Simpson N; Alaupovic P; Magder LS; Petri M
    Arthritis Care Res (Hoboken); 2015 Mar; 67(3):442-6. PubMed ID: 25155365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of peripheral blood monocytes, endothelial dysfunction and subclinical atherosclerosis in patients with systemic lupus erythematosus.
    Mikołajczyk TP; Osmenda G; Batko B; Wilk G; Krezelok M; Skiba D; Sliwa T; Pryjma JR; Guzik TJ
    Lupus; 2016 Jan; 25(1):18-27. PubMed ID: 26251402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher circulating levels of OxLDL % of LDL are associated with subclinical atherosclerosis in female patients with systemic lupus erythematosus.
    Ahmad HM; Sarhan EM; Komber U
    Rheumatol Int; 2014 May; 34(5):617-23. PubMed ID: 24101173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood ceramides as novel markers for renal impairment in systemic lupus erythematosus.
    Patyna S; Büttner S; Eckes T; Obermüller N; Bartel C; Braner A; Trautmann S; Thomas D; Geiger H; Pfeilschifter J; Koch A
    Prostaglandins Other Lipid Mediat; 2019 Oct; 144():106348. PubMed ID: 31301404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor beta 1 is associated with subclinical carotid atherosclerosis in patients with systemic lupus erythematosus.
    Gómez-Bernal F; Quevedo-Abeledo JC; García-González M; Fernández-Cladera Y; González-Rivero AF; Martín-González C; González-Gay MÁ; Ferraz-Amaro I
    Arthritis Res Ther; 2023 Apr; 25(1):64. PubMed ID: 37069672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body mass index and glucocorticoid dose contribute to subclinical atherosclerosis in Korean patients with systemic lupus erythematosus: A prospective 4 year follow-up study.
    Jung JY; Kim HA; Lee HY; Suh CH
    Int J Rheum Dis; 2019 Aug; 22(8):1410-1418. PubMed ID: 31050219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of carotid intima-media thickness and plaque in women with systemic lupus erythematosus.
    Thompson T; Sutton-Tyrrell K; Wildman RP; Kao A; Fitzgerald SG; Shook B; Tracy RP; Kuller LH; Brockwell S; Manzi S
    Arthritis Rheum; 2008 Mar; 58(3):835-42. PubMed ID: 18311797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.